tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Revenue

Compare
1,255 Followers

Fate Therapeutics Revenue

Fate Therapeutics had a revenue of 1.74M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 7.14M, Increased -15.74%. In the fiscal year ending Dec 31, 2024, Fate Therapeutics had annual revenue of 13.63M with -78.55% growth.
Revenue (ttm)
7.14M
Revenue Growth
-46.92%
P/S Ratio
8.89
Revenue/Employee
$75,309
Employees
181
Market Cap
$121.12M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
13.63M-49.90M+21.45%
Dec 31, 2023
63.53M-32.77M+65.97%
Dec 31, 2022
96.30M40.45M+172.44%
Dec 31, 2021
55.85M24.41M+177.66%
Dec 31, 2020
31.43M20.75M+294.33%
Dec 31, 2019
10.68M5.94M+225.32%
Dec 31, 2018
4.74M634.00K+115.44%
Dec 31, 2017
4.11M-296.00K+93.28%
Dec 31, 2016
4.40M